UW Medicine has announced temporary furloughs for approximately 1,500 professional and classified non-union staff to help address the financial challenges caused by COVID-19.
A study is now enrolling participants to determine whether a treatment combining a low dose of hydroxychloroquine and azithromycin can prevent hospitalization and death in people with COVID-19.
Our bodies create antibodies to recognize, neutralize and clear specific pathogens. That's why scientists are looking at neutralizing anbodies as models for therapies against the new coronavirus, SARS-CoV-2.
As we continue to see a gradual reduction in COVID-19 cases in our community, UW Medicine is welcoming more patients back for in-person visits. With that comes a variety of measures to keep patients and staff safe.
